Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 28,868 |
|
|||||
| News | - | ||||||
| Day High | 2.10 | Low High |
|||||
| Day Low | 2.035 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Athira Pharma Inc | ATHA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.49% | 2.05 | 12:29:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.07 | 2.035 | 2.10 | 2.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 211 | 28,868 | $ 2.07 | $ 59,865 | - | 1.33 - 4.2984 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:29:06 | 100 | $ 2.05 | USD |
Athira Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 78.57M | 38.33M | - | 1.63M | -117.67M | -3.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Athira Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATHA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.16 | 2.26 | 2.021 | 2.09 | 145,373 | -0.11 | -5.09% |
| 1 Month | 2.58 | 2.825 | 2.021 | 2.41 | 220,893 | -0.53 | -20.54% |
| 3 Months | 3.09 | 4.2984 | 2.021 | 3.04 | 368,772 | -1.04 | -33.66% |
| 6 Months | 1.61 | 4.2984 | 1.33 | 2.68 | 346,860 | 0.44 | 27.33% |
| 1 Year | 2.79 | 4.2984 | 1.33 | 2.71 | 271,301 | -0.74 | -26.52% |
| 3 Years | 18.07 | 23.6399 | 1.33 | 7.12 | 433,954 | -16.02 | -88.66% |
| 5 Years | 19.95 | 34.79 | 1.33 | 9.17 | 419,571 | -17.90 | -89.72% |
Athira Pharma Description
| Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. |
